Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

About Me

UniqueThis

Posted by - UniqueThis -

on - Jul 22 -

Filed in - Health -

61 Views - 0 Comments - 0 Likes - 0 Reviews

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that have attracted attention from regulators

Read Full News Here

Photos
Music Albums

Photos

0 albums found

Close Player

Minimize Player Maximize Player

Songs

Compare

Related News

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

Photos

Music Albums